Jane Street’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Jane Street’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-35,840	Closed	-$50K	–	4393
2015 Q1	$50K	Buy	+35,840	New	+$50K	﹤0.01%	3038
2014 Q4	–	Sell	-26,318	Closed	-$54K	–	3507
2014 Q3	$54K	Sell	26,318 -21,085	-44%	-$43.3K	﹤0.01%	2415
2014 Q2	$145K	Buy	47,403 +15,893	+50%	+$48.6K	﹤0.01%	2292
2014 Q1	$79K	Sell	31,510 -47,503	-60%	-$119K	﹤0.01%	2546
2013 Q4	$392K	Buy	79,013 +43,351	+122%	+$215K	0.01%	1424
2013 Q3	$81K	Sell	35,662 -9,128	-20%	-$20.7K	﹤0.01%	2568
2013 Q2	$99K	Buy	+44,790	New	+$99K	﹤0.01%	2441

Other funds holding RXII

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

HCMT

Highland Capital Management (Texas) Dallas, Texas $39M AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Jane Street's RXII Position: Q2 2015 in Review

Jane Street sold out of GALENA BIOPHARMA INC COM (RXII) in Q2 2015, closing a stake of 35,840 shares — an estimated $50K sold.

Jane Street first reported a position in RXII in Q2 2013 and held it in 7 quarters. The position peaked at $392K in Q4 2013. 86 funds tracked by Wall St. Rank hold RXII as of Q2 2015.

Jane Street reported no remaining GALENA BIOPHARMA INC COM position as of Q2 2015 after selling out during the quarter.
Jane Street sold 35,840 GALENA BIOPHARMA INC COM shares in Q2 2015, an estimated $50K.
Jane Street first reported a position in GALENA BIOPHARMA INC COM in Q2 2013 and held it in 7 quarters.
Jane Street's GALENA BIOPHARMA INC COM position peaked at $392K in Q4 2013.
86 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q2 2015.

Based on Jane Street's 13F filing for Q2 2015, filed 14 Aug 2015.